Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

BACKGROUND: Mobility impairment is a common disability in MS and negatively impacts patients’ lives. OBJECTIVE: Evaluate the effect of prolonged-release (PR) fampridine (extended-release dalfampridine in the United States) on self-assessed walking disability, dynamic/static balance and safety in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hupperts, Raymond, Lycke, Jan, Short, Christine, Gasperini, Claudio, McNeill, Manjit, Medori, Rossella, Tofil-Kaluza, Agata, Hovenden, Maria, Mehta, Lahar R, Elkins, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749757/
https://www.ncbi.nlm.nih.gov/pubmed/25921050
http://dx.doi.org/10.1177/1352458515581436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749757/
https://www.ncbi.nlm.nih.gov/pubmed/25921050
http://dx.doi.org/10.1177/1352458515581436

Ejemplares similares